COMMUNIQUÉS West-GlobeNewswire

Adamas to Present at Two Upcoming Investor Conferences
22/11/2017
EMERYVILLE, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that company management is scheduled to present at two upcoming investor conferences: Richard A. King, [...]
GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor
22/11/2017
GENFIT: Positive Outcome from the 18-month Pre-Planned Safety Review by the DSMB, in RESOLVE-IT Phase 3 Clinical Trial with elafibranor Safety data, including adverse events and laboratory data, were reviewed by the [...]
GENFIT : issue positive du DSMB suite à la revue planifiée à 18 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT
22/11/2017
GENFIT : issue positive du DSMB suite à la revue planifiée à 18 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT Les données de tolérance et de sécurité d' [...]
Innate Pharma provides an update on Lirilumab
22/11/2017
INNATE PHARMA PROVIDES AN UPDATE ON LIRILUMAB Lirilumab continues to be well-tolerated in monotherapy and in combination across multiple tumor indications in an exploratory clinical program with partner Bristol-Myers [...]
Innate Pharma annonce une mise à jour du programme Lirilumab
22/11/2017
INNATE PHARMA ANNONCE UNE MISE A JOUR DU PROGRAMME LIRILUMAB Dans le programme clinique exploratoire mené par Bristol-Myers Squibb, lirilumab continue d'être bien toléré en monothérapie et en combinaison dans [...]
Sienna Senior Living named one of Canada’s Most Admired Corporate Cultures for 2017
22/11/2017
MARKHAM, Ontario, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Sienna Senior Living (TSX: SIA ) (“ Sienna ”) announced today that it has been named among Canada’s Most Admired Corporate Cultures in the Enterprise category by [...]
Analogic Announces Timing for First Quarter 2018 Earnings Conference Call and Webcast
22/11/2017
PEABODY, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ) announced today that it will conduct a conference call on Wednesday, December 6, 2017, at 5:00 p.m. (ET) to discuss results for the [...]
Axim Biotechnologies Reports Third Quarter 2017 Results
22/11/2017
NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter ended September 30, [...]
Dr. Robert M. Taft Installed as President of the American College of Prosthodontists
22/11/2017
Chicago, IL, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Robert M. Taft, DDS, FACP , has been installed as president of the American College of Prosthodontists (ACP) . Dr. Taft was sworn in during the 47 th Annual Session of the [...]
Aquinox to Participate in 29th Annual Piper Jaffray Healthcare Conference
22/11/2017
VANCOUVER, British Columbia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in [...]
Van Leeuwenhoeck Institute Updates Immuron Research Coverage
22/11/2017
MELBOURNE, Australia, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (the “Company”) wishes to advise investors that Van Leeuwenhoeck Institute, a prominent European and US-based Life Sciences Research and [...]
Collegium to Present at the 29th Annual Piper Jaffray Healthcare Conference
22/11/2017
CANTON, Mass., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that senior management will participate in a fireside chat at the 29 th Annual Piper Jaffray Healthcare [...]
Teligent, Inc. Announces First FDA Generic Approval of Hydrocortisone Butyrate Lotion 0.1%
22/11/2017
BUENA, N.J., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Vilacto Bio Inc. speeds up cooperation with Pharma GP to reach higher targets
22/11/2017
COPENHAGEN, Denmark, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI), is pleased to announce that within the next 3 month, the company will be taking over the online sales from Pharma GP direct to [...]
Novan to Present at Piper Jaffray 29th Annual Healthcare Conference
22/11/2017
MORRISVILLE, N.C., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that Nathan Stasko, PhD, President and Chief Scientific Officer of Novan, is scheduled to [...]
Alder BioPharmaceuticals® to Present at 29th Annual Piper Jaffray Healthcare Conference
22/11/2017
BOTHELL, Wash., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that it will [...]
American Health Council Honors Paul M. Colombani, MD, FACS, FAAP as “Best in Medicine”
22/11/2017
NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Dr. Paul M. Colombani, Chairman of the Pediatric Surgery at Johns Hopkins All Children's Hospital, Professor of Surgery, Pediatrics and Oncology at the Johns Hopkins [...]
DiaMedica Therapeutics Announces Ethics Committee Clearance at First Site to Initiate REMEDY Phase 2 Trial for Acute Ischemic Stroke
22/11/2017
MINNEAPOLIS, Nov. 22, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX Venture:DMA) (OTCQB:DMCAF), announced it has received ethics committee approval to initiate the first clinical site for [...]
Athenex to Present at 29th Annual Piper Jaffray Healthcare Conference
22/11/2017
BUFFALO, N.Y., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Pages